During the early stages of the Covid-19 pandemic a substantial reduction in new HIV infections and diagnoses occurred among MSM in Australia, primarily due to a decrease in the number of sexual partners. Read more in this latest study! 🔗👉 ow.ly/He4Z50XzVFl

Although transgender women living with HIV in France have a high viral suppression rate, structural barriers such as difficulties obtaining health insurance and gender-concordant identity documents persist and may impede optimal health outcomes. 🔗👉 ow.ly/khuu50Xu7JT

Health-related quality of life among people with #HIV at low-to-moderate risk for #atherosclerotic cardiovascular disease in the REPRIEVE Trial journals.lww.com/aidsonline/a... #hvhebron #malinf @aidsjournal.bsky.social

This study in a very large WHO database showed a consistently high in-hospital mortality risk among PLHIV compared with HIV-negative individuals during all SARS-CoV2 variant waves. Visit the link below to read, it's Open Access! 🔗👉 ow.ly/GtVu50XlHcX

A new study from Canada shows that older people with HIV infection are at increased risk of frailty and falls, which is exacerbated by inappropriately-prescribed medication, particularly the use of sedative and anti-cholinergic drugs. Read here! 👇 🔗 ow.ly/fetv50X7NFv @alicepharmd.bsky.social

Matthew Durstenfeld et al. show the PREVENT algorithm from the American Heart Association does not adequately predict #cardiovasculardisease risk in a large multicentre cohort of PWH in the USA & may lead to failure to prescribe statins to PWH unless guidelines change. 🔗 ow.ly/U7iG50X8kez

Examining the epidemiology of Kaposi Sarcoma (KS) in the US between 1996 and 2016, authors found that the KS risk was still elevated among PWH in the current treatment era and that consistent HIV control impacts prognosis. Check out this article in our latest issue! 🔗👉 ow.ly/izKf50X2PBz

Christopher deFilippi and colleagues describe the risks of sudden cardiac death among PWH followed in a substudy of the REPRIEVE trial, now published in AIDS. Check it out here! ⬇️ 🔗👉 ow.ly/yKPL50WQZWK #AIDS #suddencardiacdeath #PWH

In our current issue, David E. Vance and Junghee Lee review the role of stigma in affecting social cognition and social interactions in PWH, an overlooked and often misunderstood term in the US. 🔗👉 ow.ly/KXL650WQZHM @jungheelee.bsky.social @davidevance.bsky.social #AIDS #stigma #PWH

Check out this paper from our latest issue out NOW! Posttraumatic stress disorder was found to increase several adverse clinical outcomes among US veterans with HIV, most pronounced in the first decade post-diagnosis. 🔗👉 ow.ly/J0rx50WQXXp #HIV #posttraumaticstress #ptsd #veterans

Raphael Landovitz and Linda Nguyen present a Clinical Image of a lenacapavir injection site reaction(ISR), including pathology showing a foreign body granulomatous reaction. Check this out at the link below! 🔗👉 ow.ly/YrCH50Wu6PM @tysonwonderdog.bsky.social

In a large study of #PWH in Spain, low-level viremia was associated with an increased risk of virological failure but was not linked to higher likelihood of clinical event, providing assurance that LLV does not necessarily lead to adverse clinical outcomes. 🔗👉 ow.ly/POZq50WsuZv #AIDS

The recent reduction in US foreign aid programs has disrupted service delivery particularly for prevention & marginalised groups. US authors from Duke call on a HIV response reimagined around equity, inclusion & collective action. Read here! 🔗 ow.ly/aaOu50WBjr9 @dukeghi.bsky.social

Data from the MACS-WIHS Combined Cohort Study showed traumatic events occurring before age 18 increased cardiovascular disease risk among Men who have Sex with Men with & without HIV, underscoring the importance of trauma-informed care for this population. 🔗 ow.ly/RLBY50WrIpt

Garratt et al. analyse the relative roles of PrEP vs Test and Rx prevention approaches and conclude that while PrEP is a valuable tool, Test and Treat remains a cornerstone of prevention. 🔗👉 ow.ly/E20L50Wu4GW

An emerging challenge in HIV Rx is whether to use Long-Acting ARVs in PWH who have solitary Core Ab+ status. Mezzadri et al present data indicating it is ‘safe’ to use non-HBV active drugs in this setting. 🔗👉 ow.ly/SEYj50Wu2wL

Authors examine the potential role of AI in transforming HIV prevention. Advanced technologies like #MachineLearning, deep learning and generative AI can enhance monitoring, management & prevention that reduce transmission & improve treatment outcomes. @pssinatl.bsky.social 🔗 ow.ly/QZKU50Wu0ej

This cost-effectiveness study from France showed that ART taken 4/7 days provides substantial cost savings compared with the 7/7 days strategy while maintaining treatment effectiveness. 🔗 ow.ly/pZ3p50Wp5nT #AIDS

This study from the Netherlands in our latest issue showed that impaired autonomic cardiovascular control in men with HIV, potentially related to prior ART use and insufficient virological control, might contribute to risk of HIV-associated cardiovascular disease risk. 🔗 ow.ly/8tw550WimaP

This longitudinal Spanish study among people living with HIV from the CoRIS cohort @coriscohorte.bsky.social showed that early Medical Care Interruption was associated with an increased rate of AIDS-defining events and death, emphasizing the need to bolster retention in care. 🔗 ow.ly/Omc350WaCni

Cognitive assessments for persons who inject drugs (PWID) with & without HIV participating in the John Hopkins ALIVE study showed reduced cognitive function is a predictor of death for PWID with HIV independent of frailty, HIV disease stage & comorbidity. 🔗 ow.ly/EEt450WaC4q

Check out our latest issue here! 🎉🔗 ow.ly/kOAS50W1rjM This US simulation study published in our current issue showed that long-acting injectable antiretroviral therapy use among persons with diagnosed HIV will increase viral suppression and reduce HIV-incidence. 🔗 ow.ly/fk4o50W1qSx #AIDS #HIV

Sharing our paper on routine testing for #STIs in an #HIV #PrEP program in Hanoi 🇻🇳 📍29% w/ #chlamydia or #gonorrhea 📍High prevalence of rectal CT (15%) & oral NG (12%) 📍Most were asymptomatic Multi-site testing is important! More👇🏽 journals.lww.com/aidsonline/a... @aidsjournal.bsky.social #IDSky

The sudden severe cuts in funding to USAID has led to ARV shortages in many regions in low- and middle-income countries. Hill et al. propose innovative ways to extend ARV coverage to mitigate the ARV supply crisis in this latest Fast Track article. Read OA here 👉🔗 ow.ly/utcM50VKjyS

Ukraine has an estimated HIV prevalence of 0.6%-1% with about 25% being unaware of their HIV status. This review summarizes the challenges to diagnose and provide care for PWH who fled to neighboring countries since full scale war due to Russian invasion. 🔗 ow.ly/mPyl50VIJKB

Despite forecasted declines in HIV diagnoses, this study finds the US is unlikely to achieve 90% reduction by 2030, partly due to projected rises in key demographics e.g. Hispanic/Latino MSM & PWID, highlighting the need for equitable prevention access. ow.ly/SGIn50VIIiG

I'm pleased to join @abigailmhatcher.bsky.social @nickmetheny.bsky.social and @rebeccafieldingmiller.com in suggesting a few strategies for a collective rufusal to abandon HIV science, patients, and vulnerable communities in these chaotic times.

How can HIV science resist assaults on our field? ✅ Rely on our home-grown movements ✅ Do not comply in advance ✅ Retain precise language ✅ Use our collective power ✅ Dual job: sustain science & secure safe human bodies @nickmetheny.bsky.social @kldunkle.bsky.social @rebeccafieldingmiller.com

Our May issue is here! 🙌 In this Viewpoint article, ‘A refusal to abandon HIV Science’, researchers from South Africa and the US point out the disastrous consequences of the anti-science actions in the US and call on HIV scientists to push back with focus and intent. 🔗➡️ ow.ly/Tyjv50VwAV1